• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Legal & General Global Health & Pharmaceuticals Index Trust (I) - Inc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Legal & General
Fund Summary The objective of this fund is to provide growth by tracking the performance of those companies in the FTSE World Index which are engaged in Health, Pharmaceuticals and Biotechnology activities.
SEDOL code B0CNH27
ISIN GB00B0CNH270
Fund code LGGPI
Managers Not Disclosed
Manager Tenure 6 years
Morningstar Category Sector Equity Healthcare
IMA Sector Global
Fund Size £505 million
Fund Type OEIC
Management Style Passive
Total Expense Ratio (TER) 0.31%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £0.6735
Buy Price £0.6747
Price Change +0.5065%
Price Date 14th June 2019
Yield 1.40%
Dividend Frequency Yearly
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 1st November 2000
Fund Status OPEN

3-year Mean Monthly Return: 0.987%

Annual Returns 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Fund Performance +20.35% -2.37% +24.57% -4.95% +35.68% +14.59% +30.84% +13.12% -0.75% +26.71%
Benchmark Performance
(Sector Equity Healthcare)
+15.65% -2.40% +19.65% -5.79% +34.59%
Time Period Cumulative Benchmark Performance
(Sector Equity Healthcare)
Fund Compared to Benchmark
1 day 0.51% -0.15% +0.66%
1 week 1.88% +1.50% +0.38%
1 month 6.41% +3.69% +2.73%
3 months 4.50% +1.52% +2.98%
6 months 2.16% +1.20% +0.95%
1 year 12.30% +6.07% +6.23%
3 years 43.05% +35.37% +7.68%
5 years 92.94% +72.45% +20.49%
10 years 337.07% +284.71% +52.35%
YTD 8.97% +8.18% +0.79%
Since inception 229.77% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Johnson & Johnson USA 7.75%
Pfizer Inc USA 4.74%
UnitedHealth Group Inc USA 4.68%
Merck & Co Inc USA 4.16%
Roche Holding AG Dividend Right Cert. CHE 3.78%
Novartis AG CHE 3.69%
Abbott Laboratories USA 2.77%
AbbVie Inc USA 2.49%
Medtronic PLC USA 2.46%
Amgen Inc USA 2.36%
Dividend Date Per share amount Reinvestment Price
8th January 2019 0.0092 £0.6333
8th January 2018 0.0085 £0.5941
9th January 2017 0.0080 £0.5584
8th January 2016 0.0063 £0.4732
8th January 2015 0.0061 £0.4601
8th January 2014 0.0059 £0.3554